NDAORALTABLET
Approved
Apr 2009
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
57
Mechanism of Action
Angiotensin 2 Receptor Antagonists
Pharmacologic Class:
Angiotensin 2 Receptor Blocker
Clinical Trials (5)
Study of Efficacy and Safety of LCZ696/Amlodipine in Grade 1 and 2 Hypertension Patients Uncontrolled by LCZ696 Monotherapy
Started Apr 2024
718 enrolled
Hypertension
Study of the Efficacy and Safety of LCZ696 Alone and in Combination With Amlodipine in Patients With Hypertension
Started Apr 2014
0Hypertension
Study of Efficacy and Safety of CVAA489 in Hypertensive Patients
Started Feb 2014
115 enrolled
Essential Hypertension
Study of the Safety and Efficacy of LCZ696 on Arterial Stiffness in Elderly Patients With Hypertension
Started Dec 2012
454 enrolled
Hypertension
Evaluation of the Metabolic Effects of LCZ696 and Amlodipine in Obese Hypertensive Subjects
Started Oct 2012
98 enrolled
HypertensionConcurrent Obesity